Shafer RW - Search Results

1

Comparison of the precision and sensitivity of the Antivirogram and PhenoSense HIV drug susceptibility assays.

Zhang J, Rhee SY, Taylor J, Shafer RW. Zhang J, et al. Among authors: shafer rw. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):439-44. doi: 10.1097/01.qai.0000147526.64863.53. J Acquir Immune Defic Syndr. 2005. PMID: 15764961 Free PMC article.

2

HIV-1 syncytium-inducing phenotype, virus burden, codon 215 reverse transcriptase mutation and CD4 cell decline in zidovudine-treated patients.

Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Aguiniga E, Halpern J, Merigan TC. Kozal MJ, et al. Among authors: shafer rw. J Acquir Immune Defic Syndr (1988). 1994 Aug;7(8):832-8. J Acquir Immune Defic Syndr (1988). 1994. PMID: 7517448

3

Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.

Kozal MJ, Kroodsma K, Winters MA, Shafer RW, Efron B, Katzenstein DA, Merigan TC. Kozal MJ, et al. Among authors: shafer rw. Ann Intern Med. 1994 Aug 15;121(4):263-8. doi: 10.7326/0003-4819-121-4-199408150-00005. Ann Intern Med. 1994. PMID: 7518658

4

Measurement of HIV virus load and genotypic resistance by gene amplification in asymptomatic subjects treated with combination therapy.

Holodniy M, Katzenstein D, Winters M, Montoya J, Shafer R, Kozal M, Ragni M, Merigan TC. Holodniy M, et al. J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):366-9. J Acquir Immune Defic Syndr (1988). 1993. PMID: 8095981

5

Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.

Shafer RW, Kozal MJ, Katzenstein DA, Lipil WH, Johnstone IF, Merigan TC. Shafer RW, et al. J Virol Methods. 1993 Mar;41(3):297-310. doi: 10.1016/0166-0934(93)90019-n. J Virol Methods. 1993. PMID: 8097199

6

Interlaboratory comparison of sequence-specific PCR and ligase detection reaction to detect a human immunodeficiency virus type 1 drug resistance mutation. The AIDS Clinical Trials Group Virology Committee Drug Resistance Working Group.

Shafer RW, Winters MA, Mayers DL, Japour AJ, Kuritzkes DR, Weislow OS, White F, Erice A, Sannerud KJ, Iversen A, Pena F, Dimitrov D, Frenkel LM, Reichelderfer PS. Shafer RW, et al. J Clin Microbiol. 1996 Jul;34(7):1849-53. doi: 10.1128/JCM.34.7.1849-1853.1996. J Clin Microbiol. 1996. PMID: 8784610 Free PMC article.

7

A novel approach to assessing the drug susceptibility and replication of human immunodeficiency virus type 1 isolates.

Jellinger RM, Shafer RW, Merigan TC. Jellinger RM, et al. Among authors: shafer rw. J Infect Dis. 1997 Mar;175(3):561-6. doi: 10.1093/infdis/175.3.561. J Infect Dis. 1997. PMID: 9041326

8

Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years.

Winters MA, Shafer RW, Jellinger RA, Mamtora G, Gingeras T, Merigan TC. Winters MA, et al. Among authors: shafer rw. Antimicrob Agents Chemother. 1997 Apr;41(4):757-62. doi: 10.1128/AAC.41.4.757. Antimicrob Agents Chemother. 1997. PMID: 9087484 Free PMC article. Clinical Trial.

9

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients.

Shafer RW, Winters MA, Palmer S, Merigan TC. Shafer RW, et al. Ann Intern Med. 1998 Jun 1;128(11):906-11. doi: 10.7326/0003-4819-128-11-199806010-00008. Ann Intern Med. 1998. PMID: 9634429

10

Human Immunodeficiency Virus Reverse Transcriptase and Protease Sequence Database.

Shafer RW, Stevenson D, Chan B. Shafer RW, et al. Nucleic Acids Res. 1999 Jan 1;27(1):348-52. doi: 10.1093/nar/27.1.348. Nucleic Acids Res. 1999. PMID: 9847225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

296 results

Search Page